calendar
31,077 catalysts · 18,435 approval · 4,570 device 510k · 3,381 grant · 1,935 device recall · 1,751 device pma · 1,005 recall
next 91 dayslessmore
MonWedFri
31,077 catalysts · 18,435 approval · 4,570 device 510k · 3,381 grant · 1,935 device recall · 1,751 device pma · 1,005 recall
no tagged catalysts yet
OD grant. $5,097,004. PI: RAINU KAUSHAL
AG grant. $75,052. PI: Kristi Ann Dietert
DA grant. $16,000
HL grant. $1,236,673. PI: JEAN WACTAWSKI-WENDE
HL grant. $1,121,018. PI: MARCIA STEFANICK
HL grant. $47,440. PI: MARA VITOLINS
AI grant. $499,825. PI: SCOTT SCARNEO
DA grant. $348,217
HL grant. $1,529,606
DA grant. $56,100
AI grant. $5,583,900
DA grant. $7,840
GM grant. $74,632. PI: Nicodemo Ciccia
OD grant. $4,314,261. PI: Whitney Guthrie
OD grant. $3,861,440. PI: Alexis Battle
OD grant. $3,934,201. PI: Joseph Piven
OD grant. $2,028,527. PI: KRISTEN Lyall
AG grant. $36,751. PI: In Hwa Jang
HL grant. $80,224. PI: Michael Bon-Hao Liu
DP grant. $492,348. PI: Charles Richard Jonassaint
DA grant. $8,460
DA grant. $10,000
DA grant. $45,200
DA grant. $12,000
HL grant. $38,666. PI: REBECCA JACKSON
NS grant. $538,939. PI: BARRY J BYRNE
OD grant. $4,249,149. PI: Wendy K Chung
OD grant. $3,938,148. PI: Jonathan Sebat
OD grant. $4,255,873. PI: DANIEL H GESCHWIND
AI grant. $1,999,195. PI: SEAN EKINS
HD grant. $225,000
DA grant. $21,150
DA grant. $12,421
HL grant. $1,999,671. PI: Hendree E Jones
HL grant. $9,999,898. PI: Hendree E Jones
AI grant. $498,199. PI: JUAN PIZARRO
OD grant. $3,804,755. PI: KAREN A. STARK
AA grant. $49,538. PI: Kathryn Anne Carter
AI grant. $90,946. PI: Ye Sun
Sponsor: AMNEAL. Form: TABLET. Route: ORAL
Sponsor: MYLAN. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: DANCO LABS LLC. Form: TABLET. Route: ORAL
Sponsor: ABBVIE. Form: TABLET. Route: ORAL
Sponsor: GENBIOPRO. Form: TABLET. Route: ORAL
Sponsor: ZYDUS PHARMS. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
Sponsor: IPCA LABS LTD. Form: TABLET. Route: ORAL
Sponsor: HETERO LABS LTD V. Form: TABLET. Route: ORAL
Sponsor: NOVEL LABS INC. Form: FOR SUSPENSION. Route: ORAL
Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET, EXTENDED RELEASE. Route: ORAL